Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

218

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Pain
Interventions
DRUG

Novel Ibuprofen

Single-dose of novel ibuprofen (equal to 400 mg ibuprofen)

DRUG

Acetaminophen

Single-dose of acetaminophen (1000mg)

DRUG

Placebo

Single-dose of placebo

Trial Locations (1)

84124

Pfizer Investigational Site, Salt Lake City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY